Health In Tech CTO reports 20,000 restricted shares

Health In Tech, Inc. filed an initial ownership report for Chief Technology Officer Rajagopalan Sridharan, showing beneficial ownership of 20,000 shares of Class A common stock.

Rhea-AI Filing Summary

Health In Tech, Inc. filed an initial ownership report for Chief Technology Officer Rajagopalan Sridharan, showing beneficial ownership of 20,000 shares of Class A common stock. These are restricted shares granted under the Health in Tech Equity Incentive Plan and vest in equal monthly installments over twelve months, starting on February 23, 2026, subject to his continued service with the company.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Rajagopalan Sridharan

Role Chief Technology Officer

Type	Security	Shares	Price	Value
holding	Class A Common Stock	--	--	--

Holdings After Transaction: Class A Common Stock — 20,000 shares (Direct)

Footnotes (1)

1. F1. Represent restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest in equal monthly installments over a twelve (12) month period, subject to the reporting person's continued service with the issuer through each vesting date, commencing on February 23, 2026 and continuing on each monthly anniversary thereafter until fully vested.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Health In Tech (HIT) disclose in this Form 3 filing?

Health In Tech discloses that its Chief Technology Officer, Rajagopalan Sridharan, beneficially owns 20,000 restricted shares of Class A common stock, granted under the company’s equity incentive plan and subject to a twelve-month vesting schedule starting February 23, 2026.

How many Health In Tech (HIT) shares does the CTO report owning?

The Chief Technology Officer reports beneficial ownership of 20,000 shares of Health In Tech Class A common stock. According to the filing, these are restricted shares that vest monthly over a year, contingent on his continued service with the company through each vesting date.

What are the vesting terms of the CTO’s restricted shares at Health In Tech (HIT)?

The restricted shares vest in equal monthly installments over twelve months. Vesting begins on February 23, 2026 and continues on each monthly anniversary, provided the Chief Technology Officer remains in service with Health In Tech through each applicable vesting date.

Are the reported Health In Tech (HIT) shares restricted or fully vested?

The reported 20,000 shares are restricted shares of Class A common stock. They were granted under the Health in Tech Equity Incentive Plan and will vest gradually in equal monthly installments over a twelve-month period, beginning February 23, 2026.

What plan governs the CTO’s restricted shares at Health In Tech (HIT)?

The restricted shares are granted under the Health in Tech Equity Incentive Plan. The filing states that these Class A common stock awards vest monthly over twelve months, starting February 23, 2026, subject to the executive’s continued service with the issuer.

Does this Health In Tech (HIT) Form 3 show any insider buying or selling?

The Form 3 reports initial beneficial ownership but does not show explicit buy or sell transactions. It describes 20,000 restricted shares granted under an equity incentive plan with a monthly vesting schedule tied to the executive’s ongoing service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/25/2026 - 07:27 AM EST Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Rajagopalan Sridharan

(Last) (First) (Middle)

701 S. COLORADO AVE

SUITE 1

(Street)

STUART FL 34994

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/23/2026

3. Issuer Name and Ticker or Trading Symbol
Health In Tech, Inc. [ HIT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock	20,000(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represent restricted shares of Class A Common Stock granted pursuant to the Health in Tech Equity Incentive Plan, which vest in equal monthly installments over a twelve (12) month period, subject to the reporting person's continued service with the issuer through each vesting date, commencing on February 23, 2026 and continuing on each monthly anniversary thereafter until fully vested.

	/s/ Sridharan Rajagopalan	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.